EPISODIC MIGRAINE

This study is testing whether Gou-Teng-San, a traditional herbal medicine, can help adults with episodic migraines. Researchers will randomly assign 40 participants to receive either the herbal treatment or a placebo to see if it reduces how often migraines occur and lessens thei…

This study is testing whether injections of an experimental drug called IPN10200 can help prevent migraine attacks in adults. The drug works by blocking chemical messengers in the brain that cause migraine pain. Researchers will give 641 participants with either episodic or chron…

This study is monitoring the safety and real-world effectiveness of atogepant, an already-approved oral medication for preventing migraines. It will follow 3,000 Korean adults with chronic or episodic migraines who are prescribed the drug by their doctors as part of their normal …

This study is testing whether Xeomin injections in the head and neck muscles can help prevent migraine attacks in people who get them frequently. About 990 participants will receive either the real injections or placebo shots over a year to see which group experiences fewer migra…

This study is testing whether a medication called eptinezumab, given through an IV, can safely reduce the number of migraine days for children and teenagers aged 6 to 17. It is a large, late-stage trial comparing the drug to a placebo. The main goal is to see if the treatment hel…

This study is testing whether atorvastatin, a medication typically used to lower cholesterol, can help prevent migraine attacks in adults with episodic migraine. Researchers want to confirm if results from smaller studies hold true in this larger trial with 450 participants. They…

This study aims to see how well newer migraine prevention drugs work for people in everyday life over two years. It will follow 700 patients who are already prescribed these specific medications by their doctors. Researchers will check in every six months to track headache freque…

This study is testing whether a daily pill called atogepant can safely reduce how often children and teenagers get migraines. It will involve about 450 kids aged 6 to 17 who have frequent migraine attacks. For 12 weeks, participants will take either the study drug at a low or hig…

This study is testing whether blocking several nerves in the scalp with a numbing medicine and a steroid can stop a migraine attack in progress and prevent future ones for several months. Researchers are comparing blocking just two nerves to blocking up to ten nerves to see which…